“Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma with GEMCAP and mFOLFIRINOX Regimens: Adverse Events and Long-Term Outcomes”, Вопр. онкол., vol. 72, no. 1, p. OF-2421, Mar. 2026, doi: 10.37469/0507-3758-2026-72-1-OF-2421.